InsidersTradesSigma
Track the 沛爾生醫-創 share price and the full management transaction log of the company, a listed equity based in Taiwan. Shares are quoted on the TW market, under the authority of TWSE / TPEx (MOPS). Market capitalisation: €97.7bn. The latest transaction was disclosed on 22 June 2026 (Gift). Among the most active insiders: 許家慧. Every trade is accessible without an account.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Peir Biomedical-Innovation是一家在XTAI市场上市的公司，专注于生物技术领域。该公司致力于为医疗保健行业开发创新解决方案。